文献速递垂体与肾上腺疾病

库欣综合征诊断实验室检查的准确性

Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该Meta分析纳入139项研究共14140名成人,评估过夜1mg地塞米松抑制试验(DST)、2日低剂量DST、24小时尿游离皮质醇(UFC)、深夜唾液皮质醇(LNSC)、午夜血清皮质醇(MSC)及地塞米松抑制CRH(dex-CRH)和去氨加压素(dex-DDAVP)试验的诊断准确性。结果显示所有试验均高度敏感和特异,DST最敏感,UFC敏感性较低,一线试验特异性相当。

要点

  • DST敏感性98.6%、特异性90.6%,为最敏感的试验。
  • UFC敏感性94.0%、特异性93.0%,敏感性低于DST。
  • 所有一线试验特异性相当,均高度敏感和特异。

核心结论

  • 所有纳入的库欣综合征诊断试验均高度敏感和特异,DST似乎最敏感而UFC敏感性较低,一线试验特异性相当。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Scopus、Web of Science和Cochrane系统评价数据库(从建库至2018年8月3日),纳入139项研究共14140名成人。

主要发现

  • DST敏感性98.6%(96.9%-99.4%)、特异性90.6%(86.4%-93.6%)、阳性似然比10.5(7.2-15.3)、阴性似然比0.016(0.007-0.035)。
  • 2日DST敏感性95.3%(91.3%-97.5%)、特异性92.8%(85.7%-96.5%)、阳性似然比13.2(6.47-27.1)、阴性似然比0.051(0.027-0.095)。
  • UFC敏感性94.0%(91.6%-95.7%)、特异性93.0%(89.0%-95.5%)、阳性似然比13.3(8.47-21.0)、阴性似然比0.065(0.046-0.092)。
  • LNSC敏感性95.8%(93.%-97.2%)、特异性93.4%(90.7%-95.4%)、阳性似然比14.6(10.3-20.7)、阴性似然比0.045(0.030-0.066)。
  • MSC敏感性96.1%(93.5%-97.6%)、特异性93.2%(88.1%-96.3%)、阳性似然比14.2(7.96-25.2)、阴性似然比0.042(0.026-0.069)。

关键数值与推荐

  • dex-CRH敏感性98.6%(90.4%-99.8%)、特异性85.9%(67.6%-94.7%)、阳性似然比7.0(2.80-17.6)、阴性似然比0.016(0.002-0.118)。
  • 仅一项研究评估了dex-DDAVP。
  • Meta回归和网络Meta分析提示DST最敏感而UFC最不敏感。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The diagnosis of Cushing syndrome (CS) can be challenging. It remains to be determined which diagnostic tests are the most accurate. OBJECTIVE: To summarize the accuracy of diagnostic tests for CS using contemporary meta-analytic techniques (hierarchical models). DATA SOURCES: PubMed, Embase, Scopus, Web of Science, and the Cochrane Database of Systemic Reviews (inception until August 3, 2018). STUDY SELECTION: Studies performed in adults that determined the accuracy of one or more diagnostic tests: overnight 1-mg dexamethasone suppression test (DST), 2-day low-dose DST (2d DST), 24-hour urinary free cortisol (UFC), late-night salivary cortisol (LNSC), midnight serum cortisol (MSC), and the dexamethasone-suppressed CRH (dex-CRH) and desmopressin (dex-DDAVP) tests. DATA EXTRACTION: Two authors independently extracted data and performed methodological assessments. DATA SYNTHESIS: One hundred thirty-nine studies (14 140 participants) were included in the analysis. The respective sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio (95% confidence interval [CI]) estimates include the following: DST 98.6% (96.9%-99.4%), 90.6% (86.4%-93.6%), 10.5 (7.2-15.3), and 0.016 (0.007-0.035); 2d DST 95.3% (91.3%-97.5%), 92.8% (85.7%-96.5%), 13.2 (6.47-27.1), and 0.051 (0.027-0.095); UFC 94.0% (91.6%-95.7%), 93.0% (89.0%-95.5%), 13.3 (8.47-21.0), and 0.065 (0.046-0.092); LNSC 95.8% (93.%-97.2%), 93.4% (90.7%-95.4%), 14.6 (10.3-20.7), and 0.045 (0.030-0.066); MSC 96.1% (93.5%-97.6%), 93.2% (88.1%-96.3%), 14.2 (7.96-25.2), and 0.042 (0.026-0.069); and dex-CRH 98.6% (90.4%-99.8%), 85.9% (67.6%-94.7%), 7.0 (2.80-17.6), and 0.016 (0.002-0.118). A single study evaluated dex-DDAVP. Meta-regression and a novel network meta-analytic approach suggest that DST is the most sensitive while UFC is the least sensitive. CONCLUSIONS: All of the included diagnostic tests for CS are highly sensitive and specific. It appears that the DST is the most sensitive while the UFC is less sensitive. The specificity of all first-line tests appears comparable.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Galm BP, Qiao N, Klibanski A, et al. Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome. J Clin Endocrinol Metab. 2020. PMID: 32133504. doi:10.1210/clinem/dgaa105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。